Weill Cornell Medicine Lands Fall Grants to Attack Hard-to-Treat Cancers
New awards from the AACR, Department of Defense and National Cancer Institute will fund enhancer hub research, ovarian cancer immunotherapy, ...
New awards from the AACR, Department of Defense and National Cancer Institute will fund enhancer hub research, ovarian cancer immunotherapy, ...
A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates ...
New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in ...
An NRG Oncology SPPORT trial analysis found that Luminal B prostate tumors identified by the PAM50 genomic classifier predicted a ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule achieved biochemical control and ...
A systematic review of 88 studies covering 29,256 people with prostate cancer maps preferences for digital supportive care, finding that ...
A sweeping analysis of nearly one million American men has revealed a troubling shift in the geography of aggressive prostate ...
A Barcelona team showed in fruit flies that the cancer-linked protein ETV4 activates normally silent GGAA microsatellite DNA only by ...
For men with advanced prostate cancer approaching the end of life, a routine decision about whether to continue blood thinners ...
A Charité Berlin retrospective study of 60 patients with nodal and bone oligo-recurrent prostate cancer found that early, repeatable PSMA-PET/CT-guided ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine